ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,277.51
      0.80%
      US Tech 100
      18,064.80
      0.02%
      Dow Jones
      38,686.32
      1.51%
      Brent Oil
      81.035
      0.28%
      Bitcoin
      68,311.68
      0.83%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. LSE
      6. Aston Martin Np (AMLN)

      7. Aston Martin Np (AMLN) News

      AMLN

      Aston Martin Np (AMLN)

      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:AMLN
      DateTimeSourceHeadlineSymbolCompany
      06/09/20105:02PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      06/09/20105:02PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      06/09/20104:15PMPR Newswire (US)Amylin Pharmaceuticals to Present at the Goldman Sachs 31st Annual Global Healthcare ConferenceNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      06/07/20104:15PMPR Newswire (US)Amylin Pharmaceuticals Announces Online SummitNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      06/02/20104:15PMPR Newswire (US)Amylin Pharmaceuticals to Present at the 2010 Jefferies Global Life Sciences ConferenceNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      06/01/20105:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      06/01/20108:00AMPR Newswire (US)Amylin Pharmaceuticals Appoints Christian Weyer, MD Senior Vice President, Research and DevelopmentNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      05/19/20104:15PMPR Newswire (US)Amylin Pharmaceuticals to Present at the 2010 Citi Investment Research Global Healthcare ConferenceNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      05/06/20108:15AMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      05/06/20108:15AMBusiness WireBYDUREON™ FDA Review Timeline Set with PDUFA Action Date of October 22, 2010NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      05/06/20108:00AMPR Newswire (US)BYDUREON (TM) FDA Review Timeline Set with PDUFA Action Date of October 22, 2010NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      05/03/20106:49PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      04/30/20106:34PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      04/30/20106:34PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      04/30/20106:34PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      04/30/20106:33PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      04/30/20106:33PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      04/30/20106:33PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      04/30/20106:33PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      04/30/20106:33PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      04/30/20106:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      04/30/20104:06PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      04/29/20103:38PMEdgar (US Regulatory)Confidential Treatment Order (CT ORDER)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      04/29/20103:38PMEdgar (US Regulatory)Confidential Treatment Order (CT ORDER)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      04/27/20104:15PMPR Newswire (US)Amylin Pharmaceuticals to Present at the Deutsche Bank 35th Annual Healthcare ConferenceNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      04/27/20108:00AMPR Newswire (US)Amylin Pharmaceuticals to Present at Annual Meeting of StockholdersNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      04/27/20105:49AMDow Jones NewsINTERVIEW: U.S. Victoza Roll-Out Key For Novo Nordisk - CFONASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      04/22/20105:15PMBusiness WireAmylin, Lilly and Alkermes Submit Reply to FDA Complete Response Letter for BYDUREON™NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      04/22/20105:00PMPR Newswire (US)Amylin, Lilly and Alkermes Submit Reply to FDA Complete Response Letter for BYDUREON(TM)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      04/19/201011:21AMDow Jones NewsUPDATE: Amylin 1Q Loss Narrows;To File FDA Response This WeekNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
       Showing the most relevant articles for your search:NASDAQ:AMLN

      Your Recent History

      AQSE
      CLBS.GB
      Celebrus Technologies
      BIT
      P34316
      Bnp Paribas Issuance
      Delayed Upgrade Clock